Skip to main content

Peer Review reports

From: Cost-effectiveness analysis of ranibizumab for retinal vein occlusion patients in China from the societal perspective

Original Submission
11 Mar 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
6 Apr 2021 Reviewed Reviewer Report - Yoshihito Sakanishi
8 Apr 2021 Reviewed Reviewer Report - Tanapat Ratanapakorn
23 Apr 2021 Author responded Author comments - Jing Wu
Resubmission - Version 3
23 Apr 2021 Submitted Manuscript version 3
1 May 2021 Reviewed Reviewer Report - Yoshihito Sakanishi
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
13 May 2021 Editorially accepted
24 May 2021 Article published 10.1186/s12886-021-01997-1

You can find further information about peer review here.

Back to article page